Presentations RELAPA 2
Introduction to the meeting objectives and agenda
- Ma. Elisa Peichoto, International Consultant,PANAFTOSA/VPH-PAHO/WHO | PPT
RELAPA’s Evolution: From Its Inception to the Present – Project: “An integrative approach to improve the management of snakebite envenoming in Latin America”
- Marco Vigilato, Regional Advisor on Zoonoses and Veterinary Public Health and Coordinator of the Zoonoses Program/Area, PANAFTOSA/VPH-PAHO/WHO | PPT
Strategic Fund: Mechanisms, Opportunities, and Challenges for the Availability and Access to Antivenoms in the Region
- Nora Girón, FE-PAHO/WHO, | PPT
The Importance of Strengthening and Integrating Value Chains in the Manufacturing of Health Technologies, Including Antivenoms
- María de los Ángeles Cortés, IMT/RP-PAHO/WHO | PPT
2025 Survey Analysis: An Updated Regional Perspective on the Status of Public Laboratories Manufacturing Antivenoms
- Ma. Elisa Peichoto, International Consultant, PANAFTOSA/VPH-PAHO/WHO | PPT
2025 Survey Analysis: Updated Regional Perspective on Compliance with Quality and Regulatory Standards in Antivenom Manufacturing
- Murilo Freitas Dias, IMT-QR-PAHO/WHO | PPT
Actions to Strengthen Antivenom Manufacturing Laboratories in the Region
- Working in Groups | PPT
Instituto Vital Brazil visit
- Luis Eduardo R. Da Cunha, Vice President Instituto Vital Brazil | PPT
Production of Hyperimmune Sera at the Instituto Vital Brazil
- Camila Braz Pereira da Costa, Industrial Director, Instituto Vital Brazil | PPT
Challenges and Perspectives of Venomous Snake Breeding, Herpetology and Research Center, Instituto Vital Brazil
- Guilherme Jones Souza, Biologist, Herpetology and Research Center, Instituto Vital Brazil | PPT
Challenges in Antivenom Production and Quality Control: Evaluating the Situation in Specific Local Contexts
- Dra. Fan Hui Wen, Technical Director of Serum Manufacturing, Butantan | PPT
Regulatory Challenges Limiting an Antivenom Serum-Producing Laboratory’s Ability to Commercialize Outside Buenos Aires Province
- Pablo Abrahamovich, Pcial. Director, Instituto Biológico Dr. Tomas Perón | PPT
Collaborations as a Strategic Approach to Strengthen and Sustain Efforts in Brazil’s Production Sector
- Erickson Luiz de Moura, production Director, Immunobiologics Production and Research Center" | PPT
Challenges and Limitations Faced in the Production of a New Antivenom in Bolivia
- David Jose Duran Alba, Laboratory Manager – Immunoglobulin Production, INLASA | PPT
Perspectives and Efforts to Reactivate Antivenom Production in Ecuador
- Mvz. Joselyn Calderón G., M.Sc. Zoonosis and One Health, Serpentarium Area Manager, INSPI | PPT
Challenges in Launching Antivenom Production in Panama
- Hildaura Acosta de Patiño, M.Sc. CIIMET-Panama University | PPT
Renovation Project to Improve Efficiency and Ensure the Quality of Antivenoms in Peru
- Noemí Sarmiento Herrera, Directora, National Center for Production and Strategic Public Health Goods, INS-Perú | PPT
Addressing Challenges as an Opportunity for Progress in Antivenom Production in Venezuela
- MSc. Mariana Cepeda, Biological Products Manager, Biotecfar | PPT
Perspectives on New Scientific and Technological Trends and Innovations in Antivenom Production
- José María Gutiérrez, Emeritus Professor, Instituto Clodomiro Picado - Costa Rica | PPT
Recombinant Alternatives to Complement or Replace Venom Use in Arachnid Venom Production
- Christian Dokmetjan, Director, National Institute for Biologicals Production - Argentina | PPT
Excellence in R&D in Antivenom Development: Study on Improving Potency and Purity at Micro-Industrial Scale"
- João Ricardo Almeida Soares, Gerente, Laboratory of Development and Technological Innovation, Instituto Vital Brazil | PPT
Optimization of the Antivenom Manufacturing Process: Increasing Purity with Production Efficiency
- Aline Andrade Martins, Biological Products Development Laboratory - Fundación Ezequiel Diaz - Brasil | PPT
Enhancement of Processes and Expansion of Production at Instituto Butantan
- Dra. Fan Hui Wen, Technical Director of Serum Manufacturing, Instituto Butantan | PPT
Perspectives on New Scientific and Technological Trends and Innovations in Antivenom Production
- Diana Marcela Pava, Executive Director, INS - Colombia | PPT
Cross Immunomodulation Among Snake Venoms Utilized as Immunogens in Antivenom Manufacturing
- Guillermo León Montero, Industrial Division Coordinator, Instituto Clodomiro Picado - Costa Rica | PPT
Network of Public Antivenom Manufacturing Laboratories (RELAPA) and PAHO's Strategy for Poisonous Animal Incidents
- Marco Vigilato, Regional Advisor on Zoonoses and Veterinary Public Health, and Coordinator of the Zoonoses Area, PANAFTOSA/VPH-PAHO/WHO | PPT